Capital Flow Monitor · Sponsors · CIK 2117706

Pacegenix, Inc.

245 1ST ST, 18TH FLOOR, CAMBRIDGE, MA, 02142 · 6126850244

Biotechnology · Corporation· inc. DELAWARE true 2024

Fit score

Offering

$22.5M

Sold

$22.5M

% sold

100.0%

Investors

15

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-03-26 D ·current 506(b) $22.5M $22.5M 100.0% 15 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Jay Glenn Wohlgemuth — Executive Officer / Director, Cambridge, MA
  • Raymond Tabibiazar — Director, Cambridge, MA
  • Fredric Neville Eshelman — Director, Cambridge, MA
  • Frank Grazzini, II — Executive Officer, Cambridge, MA

Placement agents

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.